Core Insights - UnitedHealth (NYSE: UNH) has experienced a significant decline in stock price, dropping nearly 30% from approximately $600 in early April to $295, marking a plunge into deeply oversold territory with a Relative Strength Index (RSI) of 27.78, a level not seen since the 2008 financial crisis [1][2][5] Group 1: Stock Performance and Technical Indicators - The RSI below 30 indicates that UNH is oversold and may be poised for a rebound, as seen in previous instances when the stock hit similar levels [2] - The stock has found some stability after an insider initiative to purchase a large number of shares, which has helped boost investor confidence [7] Group 2: Leadership and Regulatory Challenges - The troubles for UNH began with the abrupt resignation of CEO Andrew Witty on May 13, leading to the suspension of the company's 2025 financial outlook due to rising medical costs and increased demand for care [5][6] - Stephen Hemsley, former CEO, has returned to stabilize the company, expressing disappointment in recent performance but maintaining confidence in long-term growth [6] Group 3: Analyst Ratings and Market Sentiment - Truist has cut UnitedHealth's price target from $580 to $360 while maintaining a "Buy" rating, citing suspended guidance and leadership changes as key factors [7] - TD Cowen downgraded UNH to "Hold," reducing its target from $520 to $308, attributing this to coding pressures, regulatory changes, and ongoing investigations [8]

Group 1 - Okta Inc (NASDAQ:OKTA) has experienced a significant pullback of 12.6% since the beginning of April, following a two-year high of $118.07 on March 24 [1] - The stock is currently interacting with its 126-day moving average, which is historically considered a bullish signal [1] - The stock has maintained a year-to-date gain of 16.9% and is in "oversold" territory with a 14-day relative strength index (RSI) of 15.2, indicating potential for a short-term bounce [4] Group 2 - For the first time in at least eight of the last ten trading days, Okta's stock is within one standard deviation of the 126-day trendline, after spending over 75% of the last six months above it [2] - Historical data shows that after similar occurrences in the past three years, Okta's stock was higher one month later 100% of the time, with an average gain of 28.7% [2]

RSI at 4H $BTC indicates the asset is oversold 🕯Previously, Bitcoin always bounced from these levels.All is not lost https://t.co/IxZPTn12X9 ...